Coronary Artery Disease - From Genetics to Drug Development

Learn about coronary artery disease through a comprehensive research conference presentation that explores genetic studies, risk factors, and drug development. Delve into advanced topics including Affymetrix chips, polygenic risk variance, noncoding regions, and computational approaches in cardiovascular genetics. Explore the relationship between genetics and coronary disease, examining microRNAs, Mendelian evangelization, cholesterol, LDL, and functional genomics. Discover cutting-edge developments in target discovery, antisense technology, and security randomization while understanding how genetic risk scores and risk alleles contribute to disease management. Presented by Dr. Ruth McPherson, Director of the Ruddy Canadian Cardiovascular Genetics Centre and Professor at the University of Ottawa, this hour-long talk provides valuable insights into the intersection of genetics and cardiovascular medicine.